These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 7617470)

  • 21. [Oral contrast media for magnetic resonance tomography of the abdomen. 1. Comparative animal studies of positive and negative contrast media].
    Laniado M; Kaminsky S; Semmler W; Weinmann HJ; Zurth C; Claussen C
    Rofo; 1987 Sep; 147(3):325-32. PubMed ID: 2445010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between contrast enhancement on fluid-attenuated inversion recovery MR sequences and signal intensity on T2-weighted MR images: visual evaluation of brain tumors.
    Kubota T; Yamada K; Kizu O; Hirota T; Ito H; Ishihara K; Nishimura T
    J Magn Reson Imaging; 2005 Jun; 21(6):694-700. PubMed ID: 15906343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro evaluation of alternative oral contrast agents for MRI of the gastrointestinal tract.
    Babos M; Schwarcz A; Randhawa MS; Marton B; Kardos L; Palkó A
    Eur J Radiol; 2008 Jan; 65(1):133-9. PubMed ID: 17485189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Echo-planar FLAIR imaging in patients with brain disorders: comparative studies with turbo-SE T2WI and turbo-FLAIR].
    Matoba M; Tonami H; Yokota H; Ayabe K; Okimura T; Yamamoto I
    Nihon Igaku Hoshasen Gakkai Zasshi; 1998 Mar; 58(4):129-36. PubMed ID: 9584455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Fat-suppressing STIR sequences with and without contrast media in the MRT of ENT tumors].
    Brüning R; Heuck A; Naegele M; Seelos K; Vahlensieck M; Reiser M
    Rofo; 1994 May; 160(5):412-6. PubMed ID: 8173051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnetic resonance imaging of the upper abdomen using a free-breathing T2-weighted turbo spin echo sequence with navigator triggered prospective acquisition correction.
    Klessen C; Asbach P; Kroencke TJ; Fischer T; Warmuth C; Stemmer A; Hamm B; Taupitz M
    J Magn Reson Imaging; 2005 May; 21(5):576-82. PubMed ID: 15834908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical value of ferric ammonium citrate: a positive oral contrast agent for T1-weighted MR imaging of the upper abdomen.
    Malcolm PN; Brown JJ; Hahn PF; Stillman AE; Li KC; Kawamura Y; Tanaka T; Noel JK; Molony BA; Johnson MF; Hildebolt CF
    J Magn Reson Imaging; 2000 Nov; 12(5):702-7. PubMed ID: 11050639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Fast spin echo imaging of vertebral metastasis: comparison of fat suppression techniques (FSE-CHESS, STIR-FSE)].
    Scarabino T; Giannatempo GM; Popolizio T; Scarale MG; Cammisa M; Salvolini U
    Radiol Med; 1996 Sep; 92(3):180-5. PubMed ID: 8975299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Elimination of bowel fluid artifact on abdominal DWI using oral contrast agent ferric ammonium citrate].
    Takahashi T; Kato K; Nishizawa T; Nakazawa Y
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2008 May; 64(5):573-8. PubMed ID: 18509218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Elimination of artifacts in MRCP: technical consideration].
    Ohgi K; Satoh K; Tanaka S; Higami T; Furukawa T; Akiyama H; Kimura S; Uehara K; Murata K; Higashi M
    Nihon Rinsho; 1998 Nov; 56(11):2854-8. PubMed ID: 9847609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nuclear magnetic resonance contrast enhancement study of the gastrointestinal tract of rats and a human volunteer using nontoxic oral iron solutions.
    Wesbey GE; Brasch RC; Engelstad BL; Moss AA; Crooks LE; Brito AC
    Radiology; 1983 Oct; 149(1):175-80. PubMed ID: 6611926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MR Arthrography: a proposal for solution optimization with lidocaine. An in vitro experience.
    Genovese E; Callegari L; Magenta Biasina A; Angeretti MG; Sosto P; Faletti C; Fugazzola C
    Radiol Med; 2003; 106(5-6):489-96. PubMed ID: 14735015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Superparamagnetic iron oxide-enhanced magnetic resonance imaging of hepatocellular carcinoma in rats].
    Liu X; Xu YK; Huang QL; Wu YK
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Dec; 22(12):1061-5. PubMed ID: 12480574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Technical note: dynamic analysis of the pharynx during swallowing using Turbo-FLASH magnetic resonance imaging combined with an oral positive contrast agent--a preliminary study.
    Suto Y; Kamba M; Kato T
    Br J Radiol; 1995 Oct; 68(814):1099-102. PubMed ID: 7496712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. OMR, a positive bowel contrast agent for abdominal and pelvic MR imaging: safety and imaging characteristics.
    Patten RM; Moss AA; Fenton TA; Elliott S
    J Magn Reson Imaging; 1992; 2(1):25-34. PubMed ID: 1623278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of oral contrast agents for abdominal magnetic resonance imaging.
    Kraus BB; Rappaport DC; Ros PR; Torres GM
    Magn Reson Imaging; 1994; 12(6):847-58. PubMed ID: 7968284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dilute oral iron solutions as gastrointestinal contrast agents for magnetic resonance imaging; initial clinical experience.
    Wesbey GE; Brasch RC; Goldberg HI; Engelstad BL; Moss AA
    Magn Reson Imaging; 1985; 3(1):57-64. PubMed ID: 3923293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ferrite particles for bowel contrast in MR imaging: design issues and feasibility studies.
    Hahn PF; Stark DD; Saini S; Lewis JM; Wittenberg J; Ferrucci JT
    Radiology; 1987 Jul; 164(1):37-41. PubMed ID: 3588924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Contrast enhancement effect of new oral agent (blueberry juice) for upper abdominal MR imaging].
    Hiraishi K; Sagami A; Hisada Y; Yamamoto K; Saika Y; Adachi I; Fujita O; Narabayashi I; Hasegawa H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1994 May; 54(6):539-41. PubMed ID: 8028963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preliminary evaluation of iron phytate (inositol hexaphosphate) as a gastrointestinal MR contrast agent.
    Unger EC; Fritz TA; Palestrant D; Meakem TJ; Granstrom P; Gatenby RA
    J Magn Reson Imaging; 1993; 3(1):119-24. PubMed ID: 8428077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.